Rfg Advisory, LLC Novartis Ag Transaction History

Rfg Advisory, LLC

  • $3.42 Billion
  • Q4 2024

A detailed history of Rfg Advisory, LLC transactions in Novartis Ag stock. As of the latest transaction made, Rfg Advisory, LLC holds 8,617 shares of NVS stock, worth $964,069. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,617
Previous 11,967 27.99%
Holding current value
$964,069
Previous $1.38 Million 39.1%
% of portfolio
0.02%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025
SELL
$96.78 - $117.18 $324,213 - $392,553
-3,350 Reduced 27.99%
8,617 $838,000
Q3 2024

Oct 16, 2024
BUY
$106.13 - $120.89 $1.27 Million - $1.45 Million
11,967 New
11,967 $1.38 Million
Q1 2021

Apr 19, 2021
SELL
$83.5 - $98.47 $179,692 - $211,907
-2,152 Closed
0 $0
Q4 2020

Feb 02, 2021
BUY
$78.07 - $94.43 $168,006 - $203,213
2,152 New
2,152 $202,000
Q1 2020

Apr 17, 2020
SELL
$70.67 - $99.01 $164,025 - $229,802
-2,321 Closed
0 $0
Q4 2019

Jan 22, 2020
BUY
$84.35 - $95.37 $195,776 - $221,353
2,321 New
2,321 $220,000
Q4 2018

Feb 15, 2019
SELL
$73.66 - $82.02 $173,174 - $192,829
-2,351 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$66.94 - $77.43 $157,375 - $182,037
2,351 New
2,351 $203,000
Q2 2018

Jul 25, 2018
SELL
$64.91 - $73.36 $184,409 - $208,415
-2,841 Closed
0 $0
Q1 2018

May 10, 2018
BUY
$70.39 - $84.15 $21,117 - $25,245
300 Added 11.81%
2,841 $230,000
Q4 2017

Feb 08, 2018
SELL
$72.33 - $77.64 $4,629 - $4,968
-64 Reduced 2.46%
2,541 $219,000
Q3 2017

Nov 02, 2017
SELL
$74.14 - $77.27 $48,932 - $50,998
-660 Reduced 20.21%
2,605 $223,000
Q2 2017

Nov 01, 2017
SELL
N/A
-232 Reduced 6.63%
3,265 $268,000
Q2 2017

Aug 14, 2017
BUY
N/A
407 Added 13.17%
3,497 $287,000
Q1 2017

Nov 01, 2017
BUY
N/A
3,090
3,090 $228,000

Others Institutions Holding NVS

# of Institutions
1,477
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $241B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Rfg Advisory, LLC Portfolio

Follow Rfg Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rfg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rfg Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email